We are live on ! Find out more
SCM

Soleus Capital Management Portfolio holdings

AUM $2.47B
1-Year Est. Return 115.63%
This Fund
S&P 500
This Quarter Est. Return
-13.52%
1 Year Est. Return
+115.63%
3 Year Est. Return
+435.52%
5 Year Est. Return
+604.31%
10 Year Est. Return
–
AUM
$641M
AUM Growth
-$134M
Cap. Flow
-$30.9M
Cap. Flow %
-4.83%
Top 10 Hldgs %
43.19%
Holding
88
New
23
Increased
22
Reduced
22
Closed
16

Top Buys

Rank Stock Value
1
SKIN icon
SkinHealth Systems
SKIN
+$40.8M
2
ORGO icon
Organogenesis Holdings
ORGO
+$16.9M
3
TNDM icon
Tandem Diabetes Care
TNDM
+$15.1M
4
ANAB icon
AnaptysBio
ANAB
+$14.3M
5
CUTR
Cutera, Inc.
CUTR
+$13.6M

Top Sells

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$21.8M
2
OSUR icon
OraSure Technologies
OSUR
+$20.7M
3
HOLX
Hologic
HOLX
+$17.3M
4
SNN icon
Smith & Nephew
SNN
+$12.3M
5
TXG icon
10x Genomics
TXG
+$8.07M

Sector Composition

Rank Sector Weight
1 Healthcare 87.21%
2 Consumer Staples 6.57%
3 Financials 0.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$26.3B
$69.6M 10.86%
295,541
-10,309
-3% -$2.1M
SKIN icon
2
SkinHealth Systems
SKIN
$94.9M
$42.1M 6.57%
3,276,037
+3,048,425
+1,339% +$40.8M
ORGO icon
3
Organogenesis Holdings
ORGO
$308M
$25.8M 4.02%
5,286,167
+2,746,000
+108% +$16.9M
SRDX
4
DELISTED
Surmodics
SRDX
$24.6M 3.84%
661,004
+102,564
+18% +$3.98M
FOCL
5
EDAP TMS S.A.
FOCL
$226M
$22.3M 3.48%
3,284,189
+135,580
+4% +$940K
IRMD icon
6
iRadimed
IRMD
$1.21B
$21.1M 3.29%
620,765
+190,714
+44% +$6.84M
CVS icon
7
CVS Health
CVS
$137B
$20.3M 3.17%
219,400
+126,900
+137% +$12.4M
THER
8
DELISTED
THERATECHNOLOGIES INC COM
THER
$17.8M 2.77%
7,822,412
+130,330
+2% +$296K
SKIN icon
9
CALL
SkinHealth Systems
SKIN
$94.9M
$16.7M 2.61%
+1,300,000
New +$17.4M
ACLX
10
DELISTED
Arcellx
ACLX
$16.4M 2.57%
909,739
-80,000
-8% -$1.03M
INSP icon
11
Inspire Medical Systems
INSP
$1.42B
$16.2M 2.53%
88,950
+41,050
+86% +$8.19M
KRYS icon
12
Krystal Biotech
KRYS
$9.88B
$14.1M 2.2%
214,482
-74,855
-26% -$4.66M
EPIX
13
DELISTED
ESSA Pharma
EPIX
$13.1M 2.05%
4,168,799
-55,000
-1% -$307K
ANAB icon
14
AnaptysBio
ANAB
$1.6B
$13.1M 2.04%
+643,575
New +$14.3M
ANGO icon
15
AngioDynamics
ANGO
$562M
$13M 2.02%
670,000
-356,450
-35% -$7.3M
DICE
16
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$12.7M 1.98%
815,740
-168,254
-17% -$2.89M
NRIX icon
17
Nurix Therapeutics
NRIX
$2.43B
$12.6M 1.97%
994,492
-17,146
-2% -$194K
APEN
18
DELISTED
Apollo Endosurgery, Inc.
APEN
$11.9M 1.86%
3,268,948
+375,848
+13% +$1.78M
NPCE icon
19
Neuropace
NPCE
$505M
$11.6M 1.8%
2,334,003
+10,000
+0.4% +$66K
AZN icon
20
AstraZeneca
AZN
$263B
$11.2M 1.75%
84,848
+28,500
+51% +$3.74M
TNDM icon
21
Tandem Diabetes Care
TNDM
$1.17B
$10.9M 1.7%
+183,800
New +$15.1M
VRDN icon
22
Viridian Therapeutics
VRDN
$2.13B
$9.73M 1.52%
841,018
+751,018
+834% +$10.1M
CUTR
23
DELISTED
Cutera, Inc.
CUTR
$9.66M 1.51%
+257,600
New +$13.6M
EOLS icon
24
Evolus
EOLS
$394M
$9.4M 1.47%
810,676
-557,713
-41% -$6.58M
BCAB icon
25
BioAtla
BCAB
$5.59M
$9.3M 1.45%
65,254
+14,946
+30% +$2.38M
1
2 3 4

Similar funds

TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
JC
JB Capital Wethersfield, Connecticut $2.48B AUM 22.31% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
BW
BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return

Soleus Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Soleus Capital Management held 88 positions worth $641M, down 17% from $775M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Soleus Capital Management withdrew a net $30.9M in Q2 2022, closing 16 positions and reducing 22 holdings. Its most notable exit was Illumina, an estimated $21.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 80% a quarter earlier, followed by Consumer Staples and Financials.

Against the trend, Soleus Capital Management opened a new position in Tandem Diabetes Care worth $10.9M.

  • Soleus Capital Management's largest Q2 2022 buy was Tandem Diabetes Care: 183,800 shares worth $10.9M.
  • Soleus Capital Management added most to SkinHealth Systems in Q2 2022, an estimated $40.8M increase.
  • Soleus Capital Management's biggest Q2 2022 reduction was Kyntra Bio, cutting an estimated $7.79M.
  • Soleus Capital Management fully exited Illumina in Q2 2022, selling an estimated $21.8M.
  • Soleus Capital Management's ten largest holdings make up 43% of its $641M portfolio in Q2 2022.
  • Soleus Capital Management opened 23 new positions and closed 16 in Q2 2022.
  • Soleus Capital Management's portfolio value fell 17% quarter-over-quarter to $641M.

Based on Soleus Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.